Global Cancer Statistics, 2002
By D. Parkin, F. Bray, J. Ferlay, P. Pisani. Ca, 2005
18,664 citations recorded by the source corpus.
Estimates of the worldwide incidence, mortality and prevalence of 26 cancers in the year 2002 are now available in the GLOBOCAN series of the International Agency for Research on Cancer. The results are presented here in summary form, including the geographic variation between 20 large “areas” of the world. Overall, there were 10.9 million new cases, 6.7 million deaths, and 24.6 million persons alive with cancer (within three years of diagnosis). The most commonly diagnosed cancers are lung (1.35 million), breast (1.15 million), and colorectal (1 million); the most common causes of cancer death are lung cancer (1.18 million deaths), stomach cancer (700,000 deaths), and liver cancer (598,000 deaths). The most prevalent cancer in the world is breast cancer (4.4 million survivors up to 5 years following diagnosis). There are striking variations in the risk of different cancers by geographic area. Most of the international variation is due to exposure to known or suspected risk factors related to lifestyle or environment, and provides a clear challenge to prevention.
Subfields: Epidemiology, Oncology
View Paper: https://www.semanticscholar.org/paper/b188eecc76ca241738297f518d7402f823902225
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Oncology
- Jordi Bruix1 , 2
- Lewis R. Roberts
- J. D. Yang
- J. Llovet
- Adi F. Gazdar
- Y. Nikiforov
- M. Nikiforova
- M. Li‐Weber
Citations in the corpus
- The impact of translocations and gene fusions on cancer causation (2007, background): “The main problem is that cancer incidences differ substantially among geographical regions and ethnic group”
- Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24 (2007, neutral): “dtd" [ ]> Prostate cancer is the most prevalent noncutaneous cancer in males in developed region”
- From antimicrobial to anticancer peptides. A review (2013, background): “Also, the worldwide statistics reveal that the most commonly diagnosed cancers are lung, breast and colorectal (Parkin et al., 2005; Ferlay et al., 2010).”
- Gastric cancer: epidemiology, prevention, classification, and treatment (2018, background): “In European countries, survival rates vary from ~10% to 30%.(4) High survival rate in Japan is probably achieved by early diagnosis by endoscopic examinations and consecutive early tumor resection.”